annual current liabilities:
$185.51M-$62.08M(-25.08%)Summary
- As of today (July 1, 2025), APLS annual total current liabilities is $185.51 million, with the most recent change of -$62.08 million (-25.08%) on December 31, 2024.
- During the last 3 years, APLS annual current liabilities has risen by +$53.66 million (+40.70%).
- APLS annual current liabilities is now -25.08% below its all-time high of $247.59 million, reached on December 31, 2023.
Performance
APLS Current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly current liabilities:
$178.38M-$7.13M(-3.84%)Summary
- As of today (July 1, 2025), APLS quarterly total current liabilities is $178.38 million, with the most recent change of -$7.13 million (-3.84%) on March 31, 2025.
- Over the past year, APLS quarterly current liabilities has dropped by -$36.91 million (-17.15%).
- APLS quarterly current liabilities is now -27.96% below its all-time high of $247.59 million, reached on December 31, 2023.
Performance
APLS quarterly current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Current liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
APLS Current liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -25.1% | -17.1% |
| 3 y3 years | +40.7% | +43.0% |
| 5 y5 years | +182.1% | +251.6% |
APLS Current liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -25.1% | +40.7% | -28.0% | +54.5% |
| 5 y | 5-year | -25.1% | +182.1% | -28.0% | +207.6% |
| alltime | all time | -25.1% | >+9999.0% | -28.0% | >+9999.0% |
APLS Current liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $178.38M(-3.8%) |
| Dec 2024 | $185.51M(-25.1%) | $185.51M(-3.0%) |
| Sep 2024 | - | $191.26M(+13.1%) |
| Jun 2024 | - | $169.17M(-21.4%) |
| Mar 2024 | - | $215.29M(-13.0%) |
| Dec 2023 | $247.59M(+47.7%) | $247.59M(+33.4%) |
| Sep 2023 | - | $185.63M(+6.2%) |
| Jun 2023 | - | $174.84M(+26.1%) |
| Mar 2023 | - | $138.64M(-17.3%) |
| Dec 2022 | $167.61M(+27.1%) | $167.61M(+45.2%) |
| Sep 2022 | - | $115.45M(-8.9%) |
| Jun 2022 | - | $126.79M(+1.6%) |
| Mar 2022 | - | $124.77M(-5.4%) |
| Dec 2021 | $131.85M(+2.7%) | $131.85M(+39.9%) |
| Sep 2021 | - | $94.24M(-40.3%) |
| Jun 2021 | - | $157.79M(+88.6%) |
| Mar 2021 | - | $83.67M(-34.8%) |
| Dec 2020 | $128.33M | $128.33M(+70.5%) |
| Sep 2020 | - | $75.27M(+29.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2020 | - | $57.99M(+14.3%) |
| Mar 2020 | - | $50.74M(-22.8%) |
| Dec 2019 | $65.75M(+286.2%) | $65.75M(+47.5%) |
| Sep 2019 | - | $44.57M(+25.2%) |
| Jun 2019 | - | $35.59M(+74.6%) |
| Mar 2019 | - | $20.39M(+19.7%) |
| Dec 2018 | $17.02M(+159.8%) | $17.02M(+6.2%) |
| Sep 2018 | - | $16.03M(+56.4%) |
| Jun 2018 | - | $10.25M(+40.6%) |
| Mar 2018 | - | $7.29M(+11.3%) |
| Dec 2017 | $6.55M(+80.1%) | $6.55M(-5.5%) |
| Sep 2017 | - | $6.94M(+13.4%) |
| Jun 2017 | - | $6.12M(+68.1%) |
| Dec 2016 | $3.64M(+13.7%) | $3.64M(+13.7%) |
| Dec 2015 | $3.20M(+195.9%) | $3.20M(+20.5%) |
| Sep 2015 | - | $2.66M(+109.0%) |
| Jun 2015 | - | $1.27M(+17.5%) |
| Dec 2014 | $1.08M(+59.7%) | $1.08M |
| Dec 2013 | $677.00K | - |
FAQ
- What is Apellis Pharmaceuticals annual total current liabilities?
- What is the all time high annual current liabilities for Apellis Pharmaceuticals?
- What is Apellis Pharmaceuticals annual current liabilities year-on-year change?
- What is Apellis Pharmaceuticals quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Apellis Pharmaceuticals?
- What is Apellis Pharmaceuticals quarterly current liabilities year-on-year change?
What is Apellis Pharmaceuticals annual total current liabilities?
The current annual current liabilities of APLS is $185.51M
What is the all time high annual current liabilities for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high annual total current liabilities is $247.59M
What is Apellis Pharmaceuticals annual current liabilities year-on-year change?
Over the past year, APLS annual total current liabilities has changed by -$62.08M (-25.08%)
What is Apellis Pharmaceuticals quarterly total current liabilities?
The current quarterly current liabilities of APLS is $178.38M
What is the all time high quarterly current liabilities for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high quarterly total current liabilities is $247.59M
What is Apellis Pharmaceuticals quarterly current liabilities year-on-year change?
Over the past year, APLS quarterly total current liabilities has changed by -$36.91M (-17.15%)